|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Allogene Therapeutics (NASDAQ: ALLO) through any online brokerage.
The latest price target for Allogene Therapeutics (NASDAQ: ALLO) was reported by Truist Securities on May 20, 2021. The analyst firm set a price target for 41.00 expecting ALLO to rise to within 12 months (a possible 63.09% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Allogene Therapeutics (NASDAQ: ALLO) is $25.14 last updated Mon Jun 21 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Allogene Therapeutics.
There is no upcoming split for Allogene Therapeutics.
Allogene Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.